No Data
No Data
ResMed's Q1 2025 Earnings: What to Expect
ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy
J.P. Morgan Maintains ResMed(RMD.US) With Buy Rating, Maintains Target Price $240
ResMed(RMD.US) Officer Sells US$3.41 Million in Common Stock
ResMed Executive Plans Sale of Shares
ResMed Inc Insider Plans Stock Sale
No Data
No Data